Agilon Health Inc. (AGL)
NYSE · Healthcare
Agilon Health Inc. EBITDA 2019–2025
Agilon Health Inc. annual/quarterly ebitda history and growth rate from 2019 to 2026. EBITDA stands for Earnings Before Interest, Taxes, Depreciation and Amortization. It is widely used as a measure of core operational profitability.
- Agilon Health Inc. ebitda for the quarter ending March 31, 2026 was 10.8 M, a 170.79% decrease year-over-year.
- Agilon Health Inc. ebitda for the twelve months ending March 31, 2026 was -237.0 M, a 17.75% increase year-over-year.
- Agilon Health Inc. annual ebitda for 2025 was -434.6 M, a 62.38% increase from 2024.
- Agilon Health Inc. annual ebitda for 2024 was -267.7 M, a 26.27% increase from 2023.
- Agilon Health Inc. annual ebitda for 2023 was -212.0 M, a 131.40% increase from 2022.
- Agilon Health Inc. annual ebitda for 2022 was -91.6 M.
EBITDA
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Agilon Health Inc. EBITDA — FAQ
Agilon Health Inc. (AGL) ebitda over the last 7 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see AGL's ebitda history?
The chart and table above show Agilon Health Inc.'s ebitda by year and by quarter, including the growth rate.